Prescription Drug Price Reporting Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in senate (May 23, 2019)
Prescription Drug Price Reporting Act
This bill requires that all prescription drug manufacturers submit certain information for every drug marketed in the United States to the Department of Health and Human Services (HHS). Specifically, manufacturers must provide information about cost, pricing, and rebates. Manufacturers are also required to submit any price changes to a prescription drug at least 30 days in advance.
HHS must make this information available through a public database that enables consumers to subscribe to price change notifications for different types of prescriptions drugs.
What just happenedMay 23, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Who’s behind it
- Introduced in SenateMay 23, 2019
- May 23, 2019IntroReferral
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Health, Education, Labor, and Pensions Committee - May 23, 2019IntroReferral10000
Introduced in Senate